Last reviewed · How we verify

NCT05100108

A Dog-assisted Therapy to Reduce Burnout Among Professionals Working in a School for Special Education

Status unknown NA Last updated 29 October 2021
What this trial tests

NA trial testing Dog-assisted therapy in Occupational Groups in 30 participants. Status unknown.

Timeline
26 October 2021
Primary endpoint
23 December 2021
23 December 2021

Quick facts

Lead sponsorDaniel Collado-Mateo
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date26 October 2021
Primary completion23 December 2021
Estimated completion23 December 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Daniel Collado-Mateo

Who can join

18 and older, any sex, with Occupational Groups or Work Related Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the effects of an 8-week program consisting of dog-assisted therapy on the work engagement, burnout, pain, and quality of life among professionals working in a School for Special Education. A total of 30 participants will be involved in the program, which will be comprised of eight 50-min sessions conducted once a week. The hypothesis of the researchers in this study is that this program will achieve a reduction in burnout levels in workers, as well as an improvement in engagement and quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dog-assisted therapy

Trials testing the same drug.

Other Daniel Collado-Mateo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing